Abstract
By design: Novel small-molecule inhibitors of the interaction between the von Hippel-Lindau ligase (VHL) and its molecular target HIF1α, a transcription factor involved in oxygen sensing, have been developed and studied. The most potent inhibitor binds with an IC50 value of 0.9-μM and is thus the first sub-micromolar inhibitor of the VHL-HIF1α interaction.
| Original language | English |
|---|---|
| Pages (from-to) | 11463-11467 |
| Number of pages | 5 |
| Journal | Angewandte Chemie - International Edition |
| Volume | 51 |
| Issue number | 46 |
| DOIs | |
| State | Published - Nov 12 2012 |
Keywords
- drug design
- E3 ubiquitin ligases
- protein crystallography
- protein-protein interactions
- structure-based design
Fingerprint
Dive into the research topics of 'Small-molecule inhibitors of the interaction between the E3 ligase VHL and HIF1α'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver